The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Impairment | - | 14,119,955 |
| Net loss | -3,302,459 | -5,350,662 |
| Depreciation | 16,155 | 217,443 |
| Stock-based compensation | 9,836 | 63,539 |
| Shares issued for services | - | 473,413 |
| Non-cash interest | 499,174 | 2,966,853 |
| Non-cash transaction cost | - | 6,086,870 |
| Changes in fair value of financial liabilities | - | 34,333,573 |
| Plant and equipment disposal loss | - | -158,093 |
| Foreign exchange (gain) / loss | 7,129 | 621 |
| Other current assets and premises lease deposits | -440,643 | 684,310 |
| Accounts receivable | 58,392 | -34,861 |
| Accounts payable and accrued liabilities | 623,207 | -3,353,505 |
| Deferred revenue | 33,381 | 43,722 |
| Operating lease | -3,602 | -38,774 |
| Customer deposits | -9,873 | -37,816 |
| Cash used in operating activities | -1,759,059 | -19,634,512 |
| Net cash acquired from business combination | - | 77,270 |
| Cash provided by investing activities | - | 77,270 |
| Payments on finance leases | 1,821 | 7,008 |
| Proceeds from share issuances | - | 14,767,360 |
| Proceeds from senior secured promissory notes | - | 596,000 |
| Proceeds from promissory notes | - | 929,299 |
| Repayment of promissory notes | - | 305,000 |
| Repayment of sr&ed loan | - | 727,014 |
| Proceeds from pre-paid purchase | - | 4,400,000 |
| Proceeds from convertible notes | - | 1,105,000 |
| Proceeds from convertible promissory note | - | 3,150,000 |
| Repayment of convertible promissory note | - | 2,216,168 |
| Repayment of short-term debt | 35,000 | - |
| Cash (used in) / provided by financing activities | -36,821 | 21,692,469 |
| Effect of exchange rates on cash holdings in foreign currencies | -1,577 | -8,151 |
| Net change in cash and restricted cash during the year | - | 2,135,227 |
| Net change in cash and restricted cash during the period | -1,797,457 | - |
| Cash and cash equivalents at beginning of period | 2,522,656 | 395,580 |
| Cash and cash equivalents at end of period | 725,199 | 2,522,656 |
Damon Inc. (DMNIF)
Damon Inc. (DMNIF)